SMTL ID : 3o50.2 (1 other biounit)

Crystal structure of benzamide 9 bound to AuroraA

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x LJE: N-{3-methyl-4-[(3-pyrimidin-4-ylpyridin-2-yl)oxy]phenyl}-3-(trifluoromethyl)benzamide(Non-covalent)

LJE.1: 18 residues within 4Å: Chain A: G.16, K.17, F.20, V.23, K.38, L.40, L.45, V.50, Q.53, E.57, L.86, E.87, Y.88, A.89, N.137, L.139, A.149, F.151 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.23, A:V.23, A:K.38, A:L.86, A:L.139, A:A.149, A:F.151, A:F.151, A:F.151 Hydrogen bonds: A:K.38, A:A.89 Halogen bonds: A:V.50

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cee, V.J. et al., Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor. J.Med.Chem. (2010)

Release Date

2010-08-18

Peptides

cDNA FLJ58295, highly similar to Serine/threonine-protein kinase 6: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

cDNA FLJ58295, highly similar to Serine/threonine-protein kinase 6

Related Entries With Identical Sequence